Dallah Healthcare Company SJSC
SAU:4004

Watchlist Manager
Dallah Healthcare Company SJSC Logo
Dallah Healthcare Company SJSC
SAU:4004
Watchlist
Price: 162.2 SAR 0.12% Market Closed
Market Cap: 15.8B SAR
Have any thoughts about
Dallah Healthcare Company SJSC?
Write Note

Dallah Healthcare Company SJSC
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Dallah Healthcare Company SJSC
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Dallah Healthcare Company SJSC
SAU:4004
Cash from Financing Activities
-ď·Ľ444m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
National Medical Care Company JSC
SAU:4005
Cash from Financing Activities
ď·Ľ78.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mouwasat Medical Services Company SJSC
SAU:4002
Cash from Financing Activities
-ď·Ľ344.7m
CAGR 3-Years
-11%
CAGR 5-Years
-20%
CAGR 10-Years
-13%
A
Al Hammadi Holding Co
SAU:4007
Cash from Financing Activities
-ď·Ľ257m
CAGR 3-Years
16%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
Cash from Financing Activities
ď·Ľ115.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
D
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAU:4017
Cash from Financing Activities
-ď·Ľ1.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Dallah Healthcare Company SJSC
Glance View

Market Cap
15.8B SAR
Industry
Health Care

Dallah Healthcare Co. engages in the provision and operation of healthcare programs and utilities. The company is headquartered in Riyadh, Riyadh. The company went IPO on 2012-12-16. The firm operates in the following business segments: Hospitals; Medicines, and Head Office. The Hospitals’ segment objectives are to own, manage, operate and maintain healthcare facilities. The Medicines’ segment objectives are to import, distribute, wholesale and retail medicines, as well as manufacture medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging materials. The Head Office’s segment objectives are to operate, manage and maintain healthcare facilities; wholesale and retail surgical equipment, artificial parts, handicapped and hospitals equipment, as well as other supporting services.

Intrinsic Value
116.29 SAR
Overvaluation 28%
Intrinsic Value
Price

See Also

What is Dallah Healthcare Company SJSC's Cash from Financing Activities?
Cash from Financing Activities
-444m SAR

Based on the financial report for Jun 30, 2024, Dallah Healthcare Company SJSC's Cash from Financing Activities amounts to -444m SAR.

What is Dallah Healthcare Company SJSC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
-109%

Over the last year, the Cash from Financing Activities growth was -109%.

Back to Top